Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results

World Journal of Urology

Volumn 35, Issue 5, 2017, Pages 687-693

  Auer, Thomas ^a   Edlinger, Michael ^a   Bektic, Jasmin ^a   Nagele, Udo ^b   Herrmann, Thomas ^c   Schäfer, Georg ^d   Aigner, Friedrich ^a   Junker, Daniel ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Abteilung für Urologie und Andrologie   (Austria)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Multiparametric MRI; PI RADS; Prostate cancer

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1;

AGED; CANCER GRADING; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE PROCESSING; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY;

ADP-RIBOSYLATION FACTOR 1; AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84981205681     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-016-1920-5     Document Type: Article

References (22)

1. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F, Mottet N (2014) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65(1):124–137. doi:10.1016/j.eururo.2013.09.046
2. Moore CM, Robertson NL, Arsanious N, Middleton T, Villers A, Klotz L, Taneja SS, Emberton M (2013) Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 63(1):125–140. doi:10.1016/j.eururo.2012.06.004
3. Pummer K, Rieken M, Augustin H, Gutschi T, Shariat SF (2014) Innovations in diagnostic imaging of localized prostate cancer. World J Urol 32(4):881–890. doi:10.1007/s00345-013-1172-6
4. Cash H, Maxeiner A, Stephan C, Fischer T, Durmus T, Holzmann J, Asbach P, Haas M, Hinz S, Neymeyer J, Miller K, Gunzel K, Kempkensteffen C (2015) The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy. World J Urol. doi:10.1007/s00345-015-1671-8
5. Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, Rouviere O, Logager V, Futterer JJ, European Society of Urogenital R (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22(4):746–757. doi:10.1007/s00330-011-2377-y
6. Radiology ACo MR Prostate Imaging Reporting and Data System version 2.0. Accessed April 2015, from http://www.acr.org/Quality-Safety/Resources/PIRADS/
7. Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, Margolis D, Schnall MD, Shtern F, Tempany CM, Thoeny HC, Verma S (2015) PI-RADS prostate imaging—reporting and data system: 2015, version 2. Eur Urol. doi:10.1016/j.eururo.2015.08.052
8. Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, Padhani AR, Margolis D, Macura KJ, Haider MA, Cornud F, Choyke PL (2015) Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use. Eur Urol. doi:10.1016/j.eururo.2015.08.038
9. Rothke M, Blondin D, Schlemmer HP, Franiel T (2013) PI-RADS classification: structured reporting for MRI of the prostate. Rofo 185(3):253–261. doi:10.1055/s-0032-1330270
10. Portalez D, Mozer P, Cornud F, Renard-Penna R, Misrai V, Thoulouzan M, Malavaud B (2012) Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol 62(6):986–996. doi:10.1016/j.eururo.2012.06.044
11. Roethke MC, Kuru TH, Schultze S, Tichy D, Kopp-Schneider A, Fenchel M, Schlemmer HP, Hadaschik BA (2014) Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla. Eur Radiol 24(2):344–352. doi:10.1007/s00330-013-3017-5
12. Junker D, Schafer G, Edlinger M, Kremser C, Bektic J, Horninger W, Jaschke W, Aigner F (2013) Evaluation of the PI-RADS scoring system for classifying mpMRI findings in men with suspicion of prostate cancer. Biomed Res Int 2013:252939. doi:10.1155/2013/252939
13. Schimmoller L, Quentin M, Arsov C, Hiester A, Kropil P, Rabenalt R, Albers P, Antoch G, Blondin D (2014) Predictive power of the ESUR scoring system for prostate cancer diagnosis verified with targeted MR-guided in-bore biopsy. Eur J Radiol 83(12):2103–2108. doi:10.1016/j.ejrad.2014.08.006
14. Hamoen EH, de Rooij M, Witjes JA, Barentsz JO, Rovers MM (2015) Use of the Prostate Imaging Reporting and Data System (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis. Eur Urol 67(6):1112–1121. doi:10.1016/j.eururo.2014.10.033
15. Junker D, Quentin M, Nagele U, Edlinger M, Richenberg J, Schaefer G, Ladurner M, Jaschke W, Horninger W, Aigner F (2015) Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis. World J Urol 33(7):1023–1030. doi:10.1007/s00345-014-1370-x
16. Rosenkrantz AB, Kim S, Campbell N, Gaing B, Deng FM, Taneja SS (2015) Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T. AJR Am J Roentgenol 204(3):W266–W272. doi:10.2214/AJR.14.12955
17. Muller BG, Shih JH, Sankineni S, Marko J, Rais-Bahrami S, George A, de la Rosette JJ, Merino MJ, Wood BJ, Pinto P, Choyke PL, Turkbey B (2015) Prostate cancer: interobserver agreement and accuracy with the revised prostate imaging reporting and data system at multiparametric MR imaging. Radiology. doi:10.1148/radiol.2015142818
18. Baur AD, Maxeiner A, Franiel T, Kilic E, Huppertz A, Schwenke C, Hamm B, Durmus T (2014) Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate. Invest Radiol 49(6):411–420. doi:10.1097/RLI.0000000000000030
19. Tan CH, Hobbs BP, Wei W, Kundra V (2015) Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol 204(4):W439–W448. doi:10.2214/AJR.14.13373
20. Vos EK, Litjens GJ, Kobus T, Hambrock T, Hulsbergen-van de Kaa CA, Barentsz JO, Huisman HJ, Scheenen TW (2013) Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T. Eur Urol 64(3):448–455. doi:10.1016/j.eururo.2013.05.045
21. Puech P, Sufana-Iancu A, Renard B, Lemaitre L (2013) Prostate MRI: can we do without DCE sequences in 2013? Diagn Interv Imaging 94(12):1299–1311. doi:10.1016/j.diii.2013.09.010
22. Rosenkrantz AB, Sabach A, Babb JS, Matza BW, Taneja SS, Deng FM (2013) Prostate cancer: comparison of dynamic contrast-enhanced MRI techniques for localization of peripheral zone tumor. AJR Am J Roentgenol 201(3):W471–W478. doi:10.2214/AJR.12.9737